Latest News for: dosed

Edit

Verastem Oncology Doses First Patient in TARGET-D 201 Phase 2 Registration-Directed Trial of VS-7375 Oral ...

Norfolk Daily News 17 Jun 2026
TARGET-D 201 trial to evaluate VS-7375 both as monotherapy and in combination with cetuximab for second-line treatment ... .
Edit

FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of ...

Nasdaq Globe Newswire 16 Jun 2026
Company continues to advance CYWC628 manufacturing with second ...
Edit

ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome

Nasdaq Globe Newswire 16 Jun 2026
First patient dosed in FPWR-supported Phase 2a trial of CSTI-500 for hyperphagia and neurobehavioral symptoms in PWS ... .
Edit

First human dosed with cellular reprogramming drug in longevity trial

The Washington Times 16 Jun 2026
A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the epigenetic level ... .
Edit

FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the

Enid News & Eagle 16 Jun 2026
HOUSTON, June 16, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc.
Edit

Comprehensive Healthcare implements ZING� robot for methadone dosing

Nasdaq Globe Newswire 16 Jun 2026
Comprehensive Healthcare announces the successful implementation of ZING�, a robotic methadone dosing assembly system, at its clinic in Yakima, Washington ... .
Edit

Endeavor Health researchers find a daily dose of "good bacteria" improves survival of very low birthweight babies (Edward-Elmhurst Healthcare)

Public Technologies 16 Jun 2026
) Evanston, Ill ... [...]. This is an abstract of the document ... Attachments Original document Permalink. Disclaimer ... (noodl. 132508439) .
Edit

BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of

Enid News & Eagle 16 Jun 2026
Randomized, double-blind, placebo-controlled, dose-ranging trial evaluating three once-daily oral doses of BGE-102 in participants with elevated systemic inflammation and additional cardiovascular risk factors ... .
Edit

BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, ...

Nasdaq Globe Newswire 16 Jun 2026
Randomized, double-blind, placebo-controlled, dose-ranging trial evaluating three once-daily oral doses of BGE-102 in participants with elevated systemic inflammation and additional cardiovascular risk factors ... .
Edit

ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500

The Eagle-Tribune 16 Jun 2026
... the first participant has been dosed in its Phase 2a clinical .
Edit

Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial

The Eagle-Tribune 16 Jun 2026
(Nasdaq.
Edit

Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial (Form 6-K) (Clearmind Medicine Inc)

Public Technologies 16 Jun 2026
Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial ... All healthy participants in the first stage of the trial have been treated with escalating dose levels ...
Edit

Fentanyl Users Take Daily Doses 60 Times The Lethal Level

US News 15 Jun 2026
By Dennis Thompson HealthDay ReporterMONDAY, June 15, 2026 (HealthDay News) — People who use illicit fentanyl build up a mind-boggling tolerance to... .
Edit

'That short dose of dopamine can be the only happiness someone experiences every day' - ...

Manchester Evening News 15 Jun 2026
Teenagers have been having their say on plans to ban under 16s from Snapchat, TikTok, YouTube, Instagram, Facebook and X ... .
Edit

Hillhurst Bio Doses First Subject in Phase 2a Clinical Trial of HBI-002, a Novel Therapy ...

The Facts 15 Jun 2026
... that the first subject has been dosed in its ....

Article Search

tools
×
×
×
×